mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.008 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
STF-62247 |
GDSC1000 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.12 |
0.01 |